Standard Family Office LLC Sarepta Therapeutics, Inc. Transaction History

Standard Family Office LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $320,548 - $449,360	-4,859 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $160,545 - $200,739	2,314 Added 90.92%	4,859 $378,000
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $127,665 - $298,534	1,767 Added 227.12%	2,545 $190,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $97,685 - $139,059	778 New	778 $133,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.